ERYTHROMELALGIA NEWS!

Convergence Pharmaceuticals have announced their phase 2a study of BIIB-074 in the treatment of erythromelalgia (Enrollment by invitation only) A Phase 2a Study of BIIB-074 in the Treatment of Erythromelalgia

ERYTHROMELALGIA RESEARCH 2017

Pathological nociceptors in two patients with erythromelalgia-like symptoms and rare genetic Nav 1.9 variants ( Kleggetkeit et al.,2017)

Study identifies C-nociceptors from two patients with late onset of erythromelalgia

Did you know that corticosteroids (CS) may benefit certain patients with erythromelalgia?.

Can steroids extinguish the fire on erythromelalgia?

Check out our research library for further information on EM and steroids , or

One of our members Reid Millius' and her family have genetic erythromelalgia and have been involved in experiments for NaV1.7 medicines.

Those experiments have now entered the labs of half a dozen biopharmaceutical companies. The hope: development